Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: J Heart Lung Transplant. 2013 Oct 23;33(4):412–421. doi: 10.1016/j.healun.2013.10.017

Table 3.

Adult Primary Continuous Flow LVAD Patients who completed the EQ-5D-3L by Patient Profile at: Pre-Implant, 3 months, 6 months and 12 months post implant

Post-implant
Pre-Implant
3 months
6 months
12 months
Patient Profile n QOL* % n QOL* % n QOL* % n QOL* % p-value
Level 1 262 220 84.0% 235 113 48.1% 211 73 34.6% 141 49 34.8% < 0.0001
Level 2 695 546 78.6% 649 323 49.8% 590 251 42.5% 425 172 40.5% < 0.0001
Level 3 330 236 71.5% 322 149 46.3% 301 133 44.2% 228 96 42.1% <0.0001
Level 4 175 127 72.6% 163 78 47.9% 155 67 43.2% 110 54 49.1% <0.0001
Levels 5–7 97 61 62.9% 91 44 48.4% 83 45 54.2% 66 30 45.5% 0.1

Total 1559 1190 76.3% 1460 707 48.4% 1340 569 42.5% 970 401 41.3%

P value < 0.0001 0.89 0.03 0.21

Note: The INTERMACS patient profile level is collected prior to implant. This table illustrates the breakdown of patient profile level for those patients who completed the EQ-5D questionnaire at the specified time points. The p-values in the last column reflect differences in rates of completion for each INTERMACS profile across time. The p-values in the last row reflect differences in rates of completion for each INTERMACS profile at a specified time period.

*

QOL = Patients who answered the EQ-5D-3L (Note: Those patients who did not complete the EQ-5D because they were ‘too sick’ were assigned the VAS=0 and the physical dimensions as extreme problems and were included in this table as EQ-5D form completions).